Overview

The Effects of Remifentanil on Attenuating the Hemodynamic Responses After Electroconvulsive Therapy

Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The investigators will be evaluated the effects of a single loading dose of remifentanil (1µg/kg), administered as an adjunct to sevoflurane, on duration of hemodynamic profile, seizure activity, and recovery times during electroconvulsive therapy (ECT) in patients with major depression
Phase:
Phase 4
Details
Lead Sponsor:
Inonu University
Treatments:
Remifentanil
Sevoflurane